Ready 8-Ks
50
Latest filing
August 24, 2026, 4:29 PM ET
Top materiality
0.85
Event mix
earnings ×15 · other_material ×12 · other ×8
Sentiment
21 pos · 1 neg · 28 neu
Latest earnings
reported 2026-Q2
-
Aveanna Q2 revenue up 13.7% to $670.5M; raises FY2026 guidance
Q2 revenue $670.5M (+13.7% YoY); net income $40.3M vs $27.0M; diluted EPS $0.18 vs $0.13.
-
Aveanna completes $175.5M acquisition of Family First Homecare; raises FY2026 guidance
Completed acquisition of Family First Homecare for $175.5M cash, funded from cash on hand.
-
Aveanna reprices $1.32B first lien debt, margin cut 50 bps; potential 25 bps more
Entered 13th amendment to first lien credit agreement; $1.318B term loans and $250M revolver repriced.
-
Aveanna Q1 revenue up 15.9% to $647.9M; net income $41.7M vs $5.2M; raises FY guidance
Q1 revenue $647.9M (+15.9% YoY); net income $41.7M vs $5.2M in prior-year period.
-
Aveanna Q4 revenue $662.5M (+27.4% YoY); net income $178.8M; acquires Family First Homecare
Q4 revenue $662.5M (+27.4% YoY); net income $178.8M vs $29.2M prior year.
-
Aveanna to acquire Family First Homecare for $175.5M in cash, expands pediatric home care footprint
Purchase price of $175.5 million in cash, subject to working capital and other adjustments.
-
Aveanna raises FY2025 revenue and EBITDA guidance; issues FY2026 outlook
FY2025 revenue guidance raised to ~$2.425-2.445B from >$2.375B.
-
Aveanna Q3 revenue up 22.2% to $621.9M; net income of $14.1M vs loss; raises FY guidance
Q3 revenue $621.9M (+22.2% YoY); net income $14.1M vs loss of $42.8M in prior year.
-
Aveanna Healthcare prelim Q3 revenue $616-624M, net income up ~130%
Revenue expected $616M-$624M, up ~21.0%-22.6% YoY.
-
Aveanna completes $1.325B refinancing; extends maturities, repays $415M second lien debt
New $1.325B first lien term loans refinance $886M existing loans and add $439M incremental; maturity 2032 at SOFR+3.75%.
-
Aveanna Q2 revenue $589.6M (+16.8% YoY); net income $27.0M; raises FY guidance
Q2 revenue $589.6M, up 16.8% YoY; net income $27.0M vs $13.9M.
-
Aveanna increases receivables financing facility to $275M and extends maturity by three years
Seventh Amendment to Receivables Financing Agreement raises maximum availability to $275.0 million.
-
Aveanna completes acquisition of Thrive Skilled Pediatric Care, issues 11.18M shares
Closed acquisition of Thrive SPC on June 2, 2025; issued 11,184,588 shares of common stock as merger consideration.
-
Aveanna Q1: net income $5.2M vs loss; revenue +14% to $559.2M; raises FY25 guidance
Revenue $559.2M (+14.0% YoY); gross margin 32.8% vs 29.7%.
-
Aveanna to acquire Thrive Skilled Pediatric Care for ~$75M in stock and cash
Aveanna (AVAH) to acquire Thrive SPC for ~$75M, primarily in common stock, plus cash.
-
Aveanna Q4 2024 revenue $519.9M (+8.6%), net income $29.2M vs loss; Adj. EBITDA +42.8%; FY2025 guidance
Q4 revenue $519.9M (+8.6% YoY); gross margin $171.7M (33.0%) up 15.7%.
-
Aveanna Q3 revenue $509M (+6.5% YoY); Adj EBITDA $47.8M (+32.2%); raises FY24 guidance
Q3 revenue $509.0M, up 6.5% YoY; gross margin improved to 31.4% from 30.8%.
-
Aveanna Q2 revenue $505M (+7% YoY); Adj. EBITDA up 27.3%; raises FY guidance
Revenue $505M, up 7% YoY; gross margin $158.3M (+1.9%).
-
Aveanna Q1 revenue $490.7M (+5.2%), net loss narrows to $11.2M; raises FY2024 guidance
Q1 revenue $490.7M (+5.2% YoY); gross margin $145.9M (29.7% of revenue).
-
Aveanna Q4 revenue up 6.1% to $478.8M; adjusted EBITDA +30.4%; FY2024 guidance issued
Q4 revenue $478.8M (+6.1% YoY), driven by Private Duty Services and Medical Solutions growth; Home Health & Hospice down slightly.
-
Aveanna Q3 revenue up 7.9% to $478M; net loss $102.4M on $105.1M impairment; raises FY guidance
Revenue $478.0M (+7.9% YoY); gross margin $147.3M (+9.4%).
-
Aveanna Q2 revenue up 6.5% to $472M; raises full-year guidance
Revenue $471.9M (+6.5% YoY); net income $25.6M vs loss $473.9M (absence of $470.2M goodwill impairment).